This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biosynergen, Inc.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovations of Hong-Won Suh in Therapeutic Applications
Introduction
Hong-Won Suh is a notable inventor based in Kangwon-do, South Korea. He has made significant contributions to the field of therapeutics, particularly through his innovative work related to the G2A receptor. His research focuses on addressing diseases associated with neutrophil accumulation and hyperactivity.
Latest Patents
Hong-Won Suh holds a patent for the therapeutic use of agonist ligands specific to the G2A receptor. The patent describes methods for treating diseases or disorders linked to neutrophil accumulation, excessive release of IL-8, and microbial infections. The invention involves administering lysophosphatidylcholine (LPC), sphingophosphorylcholine (SPC), or their derivatives to subjects. This therapeutic approach is particularly effective for inflammatory diseases and conditions related to ischemia-reperfusion injury.
Career Highlights
Throughout his career, Hong-Won Suh has worked with various companies, including Biosynergen, Inc. and Arimed Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Hong-Won Suh has collaborated with notable colleagues, including Yung-Hi Kim and Dong-Keun Song. These partnerships have enhanced his research and development efforts in the field of therapeutics.
Conclusion
Hong-Won Suh's contributions to the therapeutic use of G2A receptor agonist ligands highlight his innovative spirit and dedication to addressing critical health issues. His work continues to pave the way for advancements in treating inflammatory diseases and microbial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile